Colorado Pharmacy CE Requirement 24-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Addiction Medicine Part 2: Alcohol 2Course Release Date: 10/21/22
Alcohol use disorder is a serious national health problem in the United States. It is estimated that more than 14 million American adults had an alcohol use disorder in 2019, as well as 414,000 adolescents aged 12 to 17. There is a clear need for improvement in the treatment of alcohol use disorder; this course serves to review the recognition, diagnosis, and treatment of alcohol use disorder and alcohol withdrawal.
- Educating Patients: Creating Teaching Moments in Practice 4Course release date: 12/21/2022
About the Course
Effective education is essential to help patients and family gain knowledge. All healthcare professionals (HCPs) can identify teaching opportunities to assess and provide effective education. The purpose of this course is to provide HCPs with current evidence-based information to help them learn and apply skills and practice for effective patient and family teaching in a variety of settings. - Heart Failure: Evidence Review and Management 2Release Date: 8/10/2022
About the Course
Heart failure is a complex clinical syndrome associated with increasing morbidity, mortality, and economic burden. Despite evidence supporting guideline-directed therapy and management for reduction of morbidity and mortality, these medications are still underprescribed. According to the CHAMP-HF registry, among eligible patients, only 22% were prescribed essential heart failure medications per guideline recommendations ((Greene et al., 2018). Healthcare providers have an essential role in improving outcomes with heart failure by bridging the gap between guideline-directed recommendations and actual clinical practice. The learning outcomes of this activity will help clinicians understand this healthcare gap by reviewing the current evidence-based pharmacotherapy recommendations for HF treatment through analyzing clinical trials and guidelines.
- Pain Management Awareness for Pharmacists, Second Edition 2Course release date: 4/20/22About the Course:Pain is not always curable, and there are a number of approaches to its treatment. The appropriate treatment plan can vary significantly, depending on the cause of pain, patient-specific factors, and personal preference. A comprehensive pain treatment plan is often a multimodal approach, requiring the use of both pharmacological and non-pharmacological treatment options. A thorough understanding of the available therapies is necessary to provide optimal care to a patient in pain. This course serves as an overview of pain, its evaluation, and treatment (US National Library of Medicine, 2021).
- Pharmacological Management: Type 2 Diabetes in Children, 2nd Edition 3
Course release date: 1/26/2023
About the Course
This course will outline the risk factors, pathophysiology, and diagnostic criteria of type 2 diabetes. Goals of management, treatment options, and psychosocial barriers will also be addressed to guide successful multidisciplinary care of these patients. - Prescribing Controlled Substances Safely: A DEA Requirement 8
Course release date: 5/1/2023
About the Course
Nurse Practitioners (NPs), Physician Assistants (PAs), Pharmacists, and Dentists care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
- Shingles Disease Process and Vaccination for Pharmacists 1Release Date: 01/17/2022
About the Course:
Shingles causes a characteristic rash typically localized in one area of the body. Serious complications, which often depend on the rash location, can arise, such as pain that persists after the rash has cleared and even vision or hearing loss. Treatment typically focuses on antiviral therapy and symptom control. Shingles can be prevented through vaccination, which is recommended for adults over 50 since the immune system weakens with age. This course serves to review the disease process of shingles and the use of vaccinations to prevent shingles. - The Pharmacologic Management of Anxiety in Adults 2Release Date: 7/10/2023About the CourseAnxiety disorders are the most commonly diagnosed psychiatric disorders, with an estimated 264 million persons globally suffering from an anxiety disorder. It’s estimated that 19.1% of adults in the United States (U.S.) are affected by at least one anxiety disorder; this number increases to 31.9% in U.S. adolescents. Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder (PD), specific phobias, agoraphobia, social anxiety disorder (SAD), and separation anxiety disorder. This course reviews the diagnosis and pharmacological management of anxiety disorders, as well as medications which can cause or exacerbate anxiety symptoms.